Showing 2011-2020 of 2050 results for "".
- Santen Announces Scottish Medicines Consortium Approval of Verkazia for Severe Vernal Keratoconjunctivitishttps://modernod.com/news/santen-announces-scottish-medicines-consortium-approval-of-verkazia-for-severe-vernal-keratoconjunctivitis/2476148/Santen UK announced that the Scottish Medicines Consortium (SMC) has approved Verkazia eye drops emulsion containing 0.1% (1mg/ml) ciclosporin for use by NHS Scotland for the treatment of the rare disease, severe vernal keratoconjun
- Prevent Blindness Opens Nominations for 2019 Jenny Pomeroy Award for Excellence in Vision and Public Healthhttps://modernod.com/news/prevent-blindness-opens-nominations-for-2019-jenny-pomeroy-award-for-excellence-in-vision-and-public-health/2479669/Prevent Blindness is issuing a call for nominations for the 2019 Jenny Pomeroy Award for Excellence in Vision and Public Health. The award recognizes an individual, team, or organization that has made an outstanding contribution to the field of public health, and vision and eye health at a commun
- Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive Error Change in Fast-Progressing Myopic Childrenhttps://modernod.com/news/prospective-study-for-naturalvue-multifocal-demonstrates-decreased-refractive-error-change-in-fast-progressing-myopic-children/2479681/Thomas Aller, OD, presented updated findings from a prospective clinical trial of NaturalVue (etafilcon A) 1 Day Multifocal Contact Lenses at a briefing for media and industry leaders at the American Academy of Optometry (AAO) Conference in San Antonio on November 9. The NaturalVue portfolio of p
- Study: Meditation An Effective Therapy to Reduce Eye Pressure in Primary Open-Angle Glaucomahttps://modernod.com/news/study-meditation-an-effective-therapy-to-reduce-eye-pressure-in-primary-open-angle-glaucoma/2479694/A new study published in the Journal of Glaucoma shows that patients with primary open angle glaucoma showed significant improvements of both ocular and general health after participating in a program of mindful meditation focused on breathing compared to the control group. “
- Eye Health America Completes Acquisition of Tampa Bay-Based Updegraff Laser Visionhttps://modernod.com/news/eye-health-america-completes-acquisition-of-tampa-bay-based-updegraff-laser-vision/2479695/Eye Health America (EHA) announced its sixth acquisition of the year, adding Updegraff Laser Vision to its roster of prominent eye care member practices in the Southeast United States. Terms of the deal were not disclosed. The acquisition of the Tampa Bay-based practice continues to
- New Data from Johnson & Johnson Vision Highlights the Need and Potential Standards for Evidence-Based Decision-Making in Myopiahttps://modernod.com/news/new-data-from-johnson-johnson-vision-highlights-the-need-and-potential-standards-for-evidence-based-decision-making-in-myopia/2479698/Johnson & Johnson Vision announced that Noel A Brennan, PhD, the company’s Global Platform Lead for Myopia Control, will present data on myopia progression and investigational methods to control it at the 2018 American Academy of Optometry Annual Meeting, held November 7-10 in San Antonio, Te
- Johnson & Johnson Vision to Showcase New Data and Interactive Experiences at 2018 AAOpthttps://modernod.com/news/johnson-johnson-vision-to-showcase-new-data-and-interactive-experiences-at-2018-aaopt/2479707/Johnson & Johnson Vision will highlight new data at the 2018 American Academy of Optometry Annual Meeting (Academy 2018), held November 7-10 in San Antonio, Texas. Two paper presentations highlighting visual performance of photochromic contact lenses were designated among the “Most Newsworthy
- Santen Launches Verkazia for Children and Adolescents with Severe Allergic Eye Conditionhttps://modernod.com/news/santen-launches-verkazia-for-children-and-adolescents-with-severe-allergic-eye-condition/2479744/Santen UK announced the launch of Verkazia eye drops emulsion containing 0.1% (1mg/ml) ciclosporin for the treatment of the rare disease severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents. Verkazia, which has been granted orphan drug status, provides a much-n
- Johnson & Johnson Vision Launches MyAcuvue Subscription Programhttps://modernod.com/news/johnson-johnson-vision-launches-myacuvue-subscription-program/2479759/Johnson & Johnson Vision announced the launch of its MyAcuvue Subscription Program, developed to provide contact lens wearers greater access and convenience when purchasing an annual supply of Acuvue Brand contact lenses through their eye care professional. “We continue to look for way
- Melt Pharmaceuticals Initiates Clinical Development Program for its Patented MK Melt Conscious Sedation Drug Candidatehttps://modernod.com/news/melt-pharmaceuticals-initiates-clinical-development-program-for-its-patented-mk-melt-conscious-sedation-drug-candidate/2479764/Melt Pharmaceuticals, a subsidiary of Imprimis Pharmaceuticals, announced that following the presentation of clinical data on the MKO Melt (midazolam/ketamine/ondansetron) from a 611-patient IRB approved prospective, controlled, randomized, three arm comparator study at the American Academy of Op